Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be an internal version update with no changes to study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe updates are cosmetic/structural: they reorganize the Locations section and its entries (Val De Marne) and remove a footer link, without altering core trial information, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no visible changes to study details or page layout.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding status notice from the page. The clinical trial details including inclusion criteria, endpoints, and locations remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant changes to core content or location listings were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check105 days agoChange DetectedMajor update: version bumped to v3.2.0 and a prominent operating-status notice added; the previous v3.1.0 tag has been removed.SummaryDifference3%

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.